Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer

We aimed to identify prognostic factors of cancer-specific survival (CSS) in non-metastatic castration-resistant prostate cancer (M0CRPC) patients. The final analysis of this retrospective cohort included 82 patients who were diagnosed as M0CRPC between 1998 and 2018 at the University of Tokyo Hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakozaki, Yuji, Yamada, Yuta, Kawai, Taketo, Nakamura, Masaki, Takeshima, Yuta, Iwaki, Takuya, Teshima, Taro, Kinoshita, Yoshitaka, Fujii, Yoichi, Akiyama, Yoshiyuki, Sato, Yusuke, Yamada, Daisuke, Suzuki, Motofumi, Kashiwagi-Hakozaki, Mayu, Ushiku, Tetsuo, Kume, Haruki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519913/
https://www.ncbi.nlm.nih.gov/pubmed/36171391
http://dx.doi.org/10.1038/s41598-022-20319-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519913/
https://www.ncbi.nlm.nih.gov/pubmed/36171391
http://dx.doi.org/10.1038/s41598-022-20319-z

Ejemplares similares